Level D· Scientific groundwork from lab and animal studiesAnimal StudyPubMedOpen access

Experimental study on the in vitro osteogenic and chondrogenic ability of fat stem cells combined with 3D-printed porous scaffolds.

He Y., Li X., Tu Z., Chen H., Zeng H., Peng Q.

Animal Study on Osteoarthritis, Cartilage Damage, Hip Osteoarthritis, published in BMC Musculoskelet Disord (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
BMC Musculoskelet Disord (2026)
Country
England
Reported sample size
—
Source database
PubMed
PMID
41547791
PMCID
PMC12895807
DOI
10.1186/s12891-025-09476-0

Abstract (original English)

Objective Developmental Dysplasia of the Hip (DDH) is an acetabular deformity caused by stress concentration or abnormal stress during weight-bearing, and it constitutes a significant etiological factor for secondary hip osteoarthritis. Currently, there remains controversy surrounding the selection of treatment protocols for DDH. This study aims to systematically evaluate the osteogenic and chondrogenic differentiation capacities of adipose-derived stem cells (ADSCs) seeded on 3D-printed porous polycaprolactone (PCL) scaffolds in vitro, thereby opening up a new avenue for addressing osteochondral tissue defects and providing a more effective and safe therapeutic approach for patients with developmental dysplasia of the hip. Methods Rat ADSCs were seeded onto fabricated 3DPPCL scaffolds. The scaffolds' biocompatibility and support for cell adhesion were confirmed. ADSCs were then cultured under osteogenic or chondrogenic conditions. Differentiation was assessed using Alizarin Red and Alcian Blue staining for mineralization and glycosaminoglycan (GAG) deposition, respectively, RT-qPCR for key gene markers (e.g., RUNX-2, COL-II), and immunofluorescence for protein expression. Experimental groups included scaffolds modified with different concentrations of dopamine or chondroitin sulfate. Results The 3DPPCL scaffolds supported robust ADSC adhesion and proliferation. Osteogenic indu

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
AnimalsTissue ScaffoldsOsteogenesisChondrogenesisPrinting, Three-DimensionalRatsPorosityCells, CulturedCell DifferentiationTissue Engineering

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research